Sproutly nears Apollon Formularies acquisition, due diligence completed
LONDON, UK: Sproutly Canada and Apollon Formularies have announced the completion of their due diligence. Sproutly, a Canadian company that specializes in natural cannabinoids, terpenes,...
Apollon Formularies to join US OTC Market and migrate to larger exchange
LONDON, UK: Apollon Formularies plc (AQSE: APOL), a UK based international pharmaceutical company trading on the Aquis Stock Exchange, is advancing an application to join...